Vistagen Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities in USD from Q2 2010 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Vistagen Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q2 2010 to Q2 2025.
  • Vistagen Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending June 30, 2025 was -$788K, a 85.6% increase year-over-year.
  • Vistagen Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2024 was -$13.1M, a 21454% decline from 2023.
  • Vistagen Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$61K, a 91.8% increase from 2022.
  • Vistagen Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$740K, a 269% decline from 2021.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Growth (%)

Vistagen Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$788K +$4.68M +85.6% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q2 2024 -$5.47M -$5.47M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q2 2023 $0 +$175K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q2 2022 -$175K -$25.2K -16.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q2 2021 -$150K -$150K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q2 2020 $0 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q2 2019 $0 +$35.4K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q2 2018 -$35.4K -$35.4K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q2 2017 $0 +$2K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q2 2016 -$2K -$2K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q2 2015 $0 Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q2 2013 -$9.6K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q2 2010 -$5.46K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-22

Vistagen Therapeutics, Inc. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$13.1M -$13.1M -21454% Apr 1, 2024 Mar 31, 2025 10-K 2025-06-17
2023 -$61K +$679K +91.8% Apr 1, 2023 Mar 31, 2024 10-K 2025-06-17
2022 -$740K -$540K -269% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-11
2021 -$200K +$75K +27.2% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-28
2020 -$275K -$275K Apr 1, 2020 Mar 31, 2021 10-K 2022-06-23
2019 $0 +$174K Apr 1, 2019 Mar 31, 2020 10-K 2021-06-29
2018 -$174K -$172K -10775% Apr 1, 2018 Mar 31, 2019 10-K 2020-06-29
2017 -$1.6K +$238K +99.3% Apr 1, 2017 Mar 31, 2018 10-K 2019-06-25
2016 -$239K -$213K -809% Apr 1, 2016 Mar 31, 2017 10-K 2018-06-26
2015 -$26.3K Apr 1, 2015 Mar 31, 2016 10-K 2017-06-29
2013 $9.6K +$145K Apr 1, 2013 Mar 31, 2014 10-K 2015-06-29
2012 -$135K -$103K -318% Apr 1, 2012 Mar 31, 2013 10-K 2014-06-25
2011 -$32.4K +$25.4K +43.9% Apr 1, 2011 Mar 31, 2012 10-K 2013-07-18
2010 -$57.8K Apr 1, 2010 Mar 31, 2011 10-K 2012-07-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.